Home007570 • KRX
add
Ilyang Pharmaceutical Co Ltd
Previous close
₩13,200.00
Day range
₩13,070.00 - ₩13,230.00
Year range
₩9,540.00 - ₩15,550.00
Market cap
256.33B KRW
Avg Volume
215.13K
P/E ratio
20.64
Dividend yield
1.14%
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 61.98B | 5.55% |
Operating expense | 25.13B | 6.71% |
Net income | 3.54B | 90.74% |
Net profit margin | 5.71 | 80.70% |
Earnings per share | — | — |
EBITDA | 5.47B | 18.81% |
Effective tax rate | -12.00% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.04B | -44.88% |
Total assets | 437.16B | -7.73% |
Total liabilities | 195.06B | -6.71% |
Total equity | 242.11B | — |
Shares outstanding | 18.62M | — |
Price to book | 1.04 | — |
Return on assets | 1.95% | — |
Return on capital | 2.40% | — |
Cash Flow
Net change in cash
(KRW) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 3.54B | 90.74% |
Cash from operations | -4.96B | -1,020.47% |
Cash from investing | -631.93M | -176.53% |
Cash from financing | 6.16B | 27.89% |
Net change in cash | 593.18M | -90.66% |
Free cash flow | -3.34B | 7.87% |
About
Founded
1946
Website
Employees
670